Hypertrophic Cardiomyopathy Clinical Trials

The hypertrophic cardiomyopathy (HCM) clinical trials team is interested in seeing how exciting new HCM drugs can help to improve the outcomes and quality of life for those living with the HCM disease.

Feel free to call or e-mail the Knight Cardiovascular Institute research team at 503-418-1964 or by emailing . You will then be forwarded to the appropriate research team member who will be able to see if you qualify for any of the clinical trials being offered at OHSU. 

You can also find all the of heart failure clinical trials, that are currently enrolling patients, below.

Clinical Trial Name

Principal Investigator

Sub Investigators

Protocol Number

HCM Pilot Study: Hypertrophic Cardiomyopathy Pilot StudyLarisa Tereshchenko, MD PhDStephen Heitner, MDIRB00015049
LIVE-HCM/LIVE-LQTS: Exercise in Genetic Cardiovascular ConditionsStephen Heitner, MDCharles Henrikson, MD / Eric Stecker, MD / Katherine Bischof, PA-C / Meghan Chirpich Mannello, CGC / Seshadri Balaji, MD / Sriram Ravi, MD / Thomas Dewland, MDIRB00012026
 MAVERICK-HCM: A Randomized, Double-blind, Pacebo-controlled, Concentration-guided, Exploratory Study of Mavacamten (MYK-461) in Patients with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection FractionStephen Heitner, MDBabak Nazer, MD / Erin Boehm, MD / Katherine Bischof, PA-C / Lidija Breznikar McGrath, MD / Michael Shapiro, MD / Mrinal Yadava, MD / Ryan Van Woerkom, MD / Steven Mansoor, MD / Thomas Dewland, MD / Vaughn Tuchy, MD